The Face of High Drug Prices
Martin Shkreli, the founder of Turing Pharmaceutical who bought the right to Daraprim and greatly increased the price, is on trial for...
CBO Says Senate Bill Will Leave 22 Million Without Health Insurance
The Congressional Budget Office just released its score of the Better Health Reconciliation Act, the Senate Republican health care bill....
The Senate Healthcare Bill and Its Impact on Ordinary Americans
The Senate Republican healthcare bill, called the Better Care Reconciliation Act, would dramatically transform the nation’s healthcare...
Senator McConnell's Health Care Bill Has Arrived. And It Will Harm Millions
At long last, Senate Majority Leader Mitch McConnell has released the Senate version of the health care bill. And frankly, it is a...
Time to Get Tough on Drug Prices
Even the most stubborn companies—drug manufacturers and pharmacy benefit managers—are now acknowledging that high drug prices are a big...
PBMs Claim There is No Connection Between PBM Rebates and Higher Drug Price. Their Analysis Leaves O
Pharmacy benefit managers (PBMs) have recently been getting more attention and scrutiny for the role they play in increasing drug costs....
Nevada Bill to Reduce Diabetes Drug Prices Signed Into Law
Yesterday consumer advocates and unions won a sweeping victory in Nevada. SB 539, a bill to reduce the prices of drugs used to treat...
Senate HELP Committee Holds First of Three Hearings on Drug Prices
This morning the Senate Health, Education, Labor, and Pensions Committee held the first of three hearings on high drug prices. A great...
The People Harmed by High Drug Prices: Juanita Milton
With all the talk of supply chains and companies and finger pointing, the people hurt by high drug costs are often forgotten or obscured....
New Paper Observes That PBMs Are Middlemen That Obtain Huge Profits But Don't Actually Make Anyt
The evidence against pharmacy benefit managers (PBMs) just keeps piling up. A new report by Merrill Matthews and Peter Pitts of the...
